E-health provider CompuGroup Medical has entered a strategic investment partnership with private equity firm CVC Capital Partners

CompuGroup’s medical software supports medical and organisational processes in doctors' and dentist offices, pharmacies, laboratories, hospitals and social institutions.

CVC said the partnership will become effective if a holding company controlled by investment funds advised and managed by affiliates of CVC Capital Partners successfully completes a voluntary public tender offer for all outstanding shares of CompuGroup Medical at a price of €22.00 per share in cash.

The move is expected to to support the long-term innovation and growth strategy of CompuGroup.

The offer corresponds to a premium of 51.1 per cent to the volume-weighted average price over the past three months and will be subject to a minimum acceptance threshold of 17 per cent and customary regulatory conditions, including antitrust clearance.

As part of the deal, the founding family Gotthardt and related shareholder Dr. Reinhard Koop, who together hold 50.1 per cent of all shares, will continue to hold a majority share in CompuGroup Medical.

CompuGroup Medical founder Frank Gotthardt will continue to remain chairman of the administrative board, while Daniel Gotthardt continues as chief executiveand member of the Administrative Board.

Daniel Pindur, Managing Partner at CVC, said: “There are a handful of those founder-led stories in Germany, it has become a real European champion in digitiszation. We look forward to collaborating closely with the Gotthardt family and the team, leveraging CVC’s experience in strategic partnerships with founder-led family businesses. Together, we want to write the next chapter of healthcare.”

Can Toygar, senior managing Director at CVC, emphasised the need for more digital solutions in the healthcare market in light of demographic changes and professional labor shortages.

“CGM is an outstanding company, and uniquely positioned to transform healthcare in Europe, making it better and more efficient. Together, we will focus on investments in modern, data-based products and improving service quality for medical doctors, pharmacists and nursing staff,” continued Toygar.

Closing of the transaction is expected in the first half of 2025.

---